Bünemann M, Liliom K, Brandts B K, Pott L, Tseng J L, Desiderio D M, Sun G, Miller D, Tigyi G
Institut für Physiologie, Ruhr-Universität, Bochum, Germany.
EMBO J. 1996 Oct 15;15(20):5527-34.
Activation of IK(ACh) is the major effect of the vagal neutrotransmitter acetylcholine in the heart. We report that both lysosphingomyelin (D-erythro-sphingosyl-phosphorylcholine; SPC) and sphingosine 1-phosphate (SPP) activate IK(ACh) in guinea pig atrial myocytes through the same receptor with an EC50 of 1.5 and 1.2 nM, respectively. Pertussis toxin abolished the activation of IK(ACh) by either lipid. The putative receptor showed an exquisite stereoselectivity for the naturally occurring D-erythro-(2S,3R)-SPC stereoisomer, the structure of which was confirmed by mass spectroscopy and NMR. These lipids caused complete homologous and heterologous desensitization with each other but not with ACh, indicating that both act on the same receptor. This receptor displays a distinct structure-activity relationship: it requires an unsubstituted amino group because N-acetyl-SPC, lysophosphatidic acid and lysophosphatidylcholine were inactive. Because SPP and SPC are naturally occurring products of membrane lipid metabolism, it appears that these compounds might be important extracellular mediators acting on a family of bona fide G protein-coupled receptors. Expression of these receptors in the heart raises the possibility that sphingolipids may be a part of the physiological and/or pathophysiological regulation of the heart. Based on their ligand selectivity we propose a classification of the sphingolipid receptors.
IK(ACh) 的激活是迷走神经递质乙酰胆碱在心脏中的主要作用。我们报告,溶血磷脂酰胆碱(D-赤藓糖基-鞘氨醇-磷酸胆碱;SPC)和1-磷酸鞘氨醇(SPP)均可通过同一受体激活豚鼠心房肌细胞中的IK(ACh),其半数有效浓度(EC50)分别为1.5 nM和1.2 nM。百日咳毒素可消除这两种脂质对IK(ACh)的激活作用。推测的受体对天然存在的D-赤藓糖型-(2S,3R)-SPC立体异构体表现出极高的立体选择性,其结构通过质谱和核磁共振得以确认。这些脂质相互之间可引起完全的同源和异源脱敏,但对乙酰胆碱则不会,这表明二者作用于同一受体。该受体呈现出独特的构效关系:它需要一个未被取代的氨基,因为N-乙酰-SPC、溶血磷脂酸和溶血磷脂酰胆碱均无活性。由于SPP和SPC是膜脂代谢的天然产物,这些化合物似乎可能是作用于一类真正的G蛋白偶联受体的重要细胞外介质。这些受体在心脏中的表达增加了鞘脂类可能参与心脏生理和/或病理生理调节的可能性。基于它们的配体选择性,我们提出了鞘脂类受体的分类。